Phosphoinositide-3-kinase inhibitors: Evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511

Brian A. Lanman(Harvard University), Mark H. Norman(Amgen (United States)), Victor J. Cee(Amgen (United States)), Raju Subramanian(Gilead Sciences (United States)), Anthony B. Reed(Amgen (United States)), Leeanne Zalameda(Amgen (United States)), Tisha San Miguel(Amgen (United States)), Douglas A. Whittington(Amgen (United States)), Andrew S. Tasker(Amgen (United States)), Erin L. Mullady(Amgen (United States)), Liping H. Pettus(Amgen (United States)), Jian Jiang(Xuzhou Medical College), Ling Wang(Guizhou University), Paul E. Hughes(Amgen (United States)), Nancy Zhang(Amgen (United States)), Tian Wu(Guangzhou University of Chinese Medicine), Kristin L. Andrews(Amgen (United States)), John D. McCarter(Amgen (United States)), Fang‐Tsao Hong(Amgen (United States)), Ryan P. Wurz(Amgen (United States))
Bioorganic & Medicinal Chemistry Letters
November 1, 2014
Cited by 4


Related Papers